Skip to main content
Clinical Trials/NCT02453217
NCT02453217
Completed
Not Applicable

The Potential Efficacy and Acceptability of the Chinese Health Improvement Profile (CHIP) in Improving the Physical Health of People With Severe Mental Illness - A Pilot Clustered Randomised Controlled Trial

Wai-Tong Chien0 sites144 target enrollmentMarch 31, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Severe Mental Illness
Sponsor
Wai-Tong Chien
Enrollment
144
Primary Endpoint
Self-reported physical well being
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The investigators programme of research will evaluate an existing physical health care screening intervention with the aim of helping Community Psychiatric Nurses (CPN) to improve the physical health wellbeing of people with a SMI.

This pilot clustered randomised controlled trial aims to establish the potential efficacy and acceptability of the Chinese Health Improvement Profile (CHIP) in improving the physical health of people with severe mental illness.

Detailed Description

This pilot study will use a non-blinded parallel group clustered randomised controlled trial design. The study will be carried out by CPNs with community-dwelling people aged 18-65 who have a psychiatric diagnosis of SMI (i.e. schizophrenia, schizoaffective disorder, other psychotic disorder or bipolar affective disorder) and at the point of recruitment are being treated in the community. It will investigate the potential clinical impact of the use of the CHIP tool when used by CPNs with this patient group. Because the CHIP is designed to be used as both an enhanced physical health risk screening tool and as an instrument to direct appropriate clinical interventions the investigators will ask the patients' allocated CPNs to recruit consenting patients , collect outcome measure data and where appropriate use the CHIP tool with patients that they work with within their routine clinical practice. Primary objective: To test the potential efficacy and acceptability of the CHIP intervention compared to treatment as usual on patients' physical well- being over a 12 month period. Secondary objectives: To measure and compare changes in perceived mental well-being between the groups as measured at baseline, and at 6 months and 12 months after the start of the intervention. To establish differences in the objective physical health state of patients between the groups at 12 months as indicated by data routinely recorded in medical/outpatient/nursing notes during the duration of study. To establish changes in health behaviours and physical indicators of cardiovascular risk within the intervention group between baseline and 12 months after the start of the intervention.

Registry
clinicaltrials.gov
Start Date
March 31, 2016
End Date
January 31, 2019
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Wai-Tong Chien
Responsible Party
Sponsor Investigator
Principal Investigator

Wai-Tong Chien

Professor and Associate Head (Research)

The Hong Kong Polytechnic University

Eligibility Criteria

Inclusion Criteria

  • Those psychiatric outpatients under the care of the community psychiatric nursing service who are:
  • Aged 18-65 years;
  • Having a case-note diagnosis (as confirmed by a registered clinician) within the illness group entitled "severe mental illness" (SMI) containing schizophrenia, schizoaffective disorder, other psychotic disorders, depressive or bipolar affective disorder (type 1 or 2); and
  • Able to speak Chinese/English
  • Able to provide written informed consent and considered safe and competent to participate in the study (as suggested by attending psychiatrist).

Exclusion Criteria

  • Co-morbidity of learning disability or organic brain diseases.

Outcomes

Primary Outcomes

Self-reported physical well being

Time Frame: 12 months after intervention

The primary outcome will be measured using the widely used and well-established Chinese version of the physical and mental health measure (SF12v2-PCS-12 subscale).

Secondary Outcomes

  • Satisfaction with services(12 months after intervention)
  • Self-reported mental health(12 months after intervention)

Similar Trials